221 related articles for article (PubMed ID: 28387639)
1. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates.
Bedoya MA; White AM; Edgar JC; Pradhan M; Raab EL; Meyer JS
Radiology; 2017 Aug; 284(2):530-540. PubMed ID: 28387639
[TBL] [Abstract][Full Text] [Related]
2. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
[TBL] [Abstract][Full Text] [Related]
3. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
[TBL] [Abstract][Full Text] [Related]
4. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
Ng CS; Shaw AD; Bell CS; Samuels JA
AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
[TBL] [Abstract][Full Text] [Related]
5. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
[TBL] [Abstract][Full Text] [Related]
6. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes.
Kane GC; Stanson AW; Kalnicka D; Rosenthal DW; Lee CU; Textor SC; Garovic VD
Nephrol Dial Transplant; 2008 Apr; 23(4):1233-40. PubMed ID: 18256017
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous low-osmolality iodinated contrast media on patients with myasthenia gravis.
Somashekar DK; Davenport MS; Cohan RH; Dillman JR; Ellis JH
Radiology; 2013 Jun; 267(3):727-34. PubMed ID: 23360741
[TBL] [Abstract][Full Text] [Related]
8. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
[TBL] [Abstract][Full Text] [Related]
9. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
[TBL] [Abstract][Full Text] [Related]
10. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
[TBL] [Abstract][Full Text] [Related]
11. Is the use of intravenous contrast material truly safe in patients with impaired renal function?
Cohen MD
Radiology; 2009 May; 251(2):613; author reply 613-4. PubMed ID: 19401587
[No Abstract] [Full Text] [Related]
12. Renal effects of gadopentetate dimeglumine in patients with normal and impaired renal function.
Hoffmann U; Fischereder M; Reil A; Fischer M; Link J; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):149-54. PubMed ID: 15946910
[TBL] [Abstract][Full Text] [Related]
13. Glomerular filtration rate in evaluation of the effect of iodinated contrast media on renal function.
Becker J; Babb J; Serrano M
AJR Am J Roentgenol; 2013 Apr; 200(4):822-6. PubMed ID: 23521455
[TBL] [Abstract][Full Text] [Related]
14. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study.
From AM; Bartholmai BJ; Williams AW; McDonald FS
Acta Radiol; 2008 May; 49(4):409-14. PubMed ID: 18415784
[TBL] [Abstract][Full Text] [Related]
15. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
Davenport MS; Khalatbari S; Dillman JR; Cohan RH; Caoili EM; Ellis JH
Radiology; 2013 Apr; 267(1):94-105. PubMed ID: 23360737
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients.
Abujudeh HH; Kaewlai R; Kagan A; Chibnik LB; Nazarian RM; High WA; Kay J
Radiology; 2009 Oct; 253(1):81-9. PubMed ID: 19709997
[TBL] [Abstract][Full Text] [Related]
17. The use of gadolinium for arterial interventions.
Sambol EB; Van der Meer JG; Graham A; Goldstein LJ; Karwowski JK; Dayal R; Derubertis B; Kent KC
Ann Vasc Surg; 2011 Apr; 25(3):366-76. PubMed ID: 21288688
[TBL] [Abstract][Full Text] [Related]
18. Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration.
Chou SH; Wang ZJ; Kuo J; Cabarrus M; Fu Y; Aslam R; Yee J; Zimmet JM; Shunk K; Elicker B; Yeh BM
Eur J Radiol; 2011 Nov; 80(2):378-86. PubMed ID: 21470810
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography.
Sandstede JJ; Roth A; Machann W; Kaupert C; Hahn D
Eur J Radiol; 2007 Jul; 63(1):120-3. PubMed ID: 17317065
[TBL] [Abstract][Full Text] [Related]
20. Is Intravenous Administration of Iodixanol Associated with Increased Risk of Acute Kidney Injury, Dialysis, or Mortality? A Propensity Score-adjusted Study.
McDonald JS; McDonald RJ; Williamson EE; Kallmes DF
Radiology; 2017 Nov; 285(2):414-424. PubMed ID: 28708022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
